CDIO
NASDAQ · Biotechnology
Cardio Diagnostics Holdings
$1.29
+0.24 (+22.86%)
Open$1.05
Previous Close$1.05
Day High$1.39
Day Low$0.97
52W High$35.54
52W Low$20.25
Volume—
Avg Volume168.2K
Market Cap2.36M
P/E Ratio22.50
EPS$1.11
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,460.5% upside
Current
$1.29
$1.29
Target
$33.03
$33.03
$21.42
$33.03 avg
$37.66
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 758.5K | 743.9K | 754.7K |
| Net Income | -209,998 | -203,473 | -219,048 |
| Profit Margin | -27.7% | -27.4% | -29.0% |
| EBITDA | -263,366 | -243,311 | -249,018 |
| Free Cash Flow | -217,938 | -231,433 | -197,267 |
| Rev Growth | -7.2% | +1.3% | +15.3% |
| Debt/Equity | 0.72 | 0.58 | 0.60 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |